Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
We are discovering new drug targets for cancer using a combination of genomic and functional assay technologies. As part of our discovery and validation process we use DNA microarrays to determine the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results